Findings From an Analysis of Patients With Monocytic and Monocytic-Like Acute Myeloid Leukemia (AML), Including AML-M4 and AML-M5, Treated With Venetoclax (Ven) Plus Azacitidine (Aza)

被引：0

作者：

Konopleva, Marina ^{[1
]}

DiNardo, Courtney ^{[2
]}

Sun, Yan ^{[3
]}

Loghavi, Sanam ^{[2
]}

Jung, Paul ^{[3
]}

Potluri, Jalaja ^{[3
]}

Dail, Monique ^{[4
,5
]}

Chyla, Brenda ^{[3
]}

Pollyea, Daniel

机构：

[1] Montefiore Einstein Canc Ctr, New York, NY USA

[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[3] AbbVie Inc, N Chicago, IL USA

[4] Genentech Inc, San Francisco, CA 94080 USA

[5] Univ Colorado, Sch Med, Aurora, CO USA

来源：

关键词：

acute myeloid leukemia; monocytic; venetoclax; azacitidine;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

AML-095

引用

页码：S266 / S267

页数：2